Clinical Trials Directory

Trials / Conditions / Malignant Glioma of Brain

Malignant Glioma of Brain

14 registered clinical trials studyying Malignant Glioma of Brain — 1 currently recruiting.

StatusTrialSponsorPhase
WithdrawnHSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
NCT04482933
Pediatric Brain Tumor ConsortiumPhase 2
CompletedPhotodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA）
NCT06417281
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.Phase 3
RecruitingAdenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
NCT05686798
Henry Ford Health SystemPhase 1
UnknownPilot Study Evaluating the Optimization of the ORBEYE Blue Light Filter During Fluorescence-Guided Resection o
NCT04937244
Northwell HealthPhase 4
WithdrawnLITT Palliative Treatment for Patients With Malignant Gliomas
NCT03176160
Duke University—
CompletedStudy of Acetazolamide With Temozolomide in Adults With Newly Diagnosed or Recurrent Malignant Glioma
NCT03011671
University of ChicagoPhase 1
UnknownPersonalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas
NCT03423992
Xuanwu Hospital, BeijingPhase 1
CompletedA Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied
NCT03355794
Children's Hospital Medical Center, CincinnatiPhase 1
Active Not RecruitingA Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2
NCT03152318
Dana-Farber Cancer InstitutePhase 1
UnknownCAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor
NCT02839954
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1 / Phase 2
UnknownCAR-T Cell Immunotherapy in MUC1 Positive Solid Tumor
NCT02617134
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1 / Phase 2
CompletedPilot Immunotherapy Trial for Recurrent Malignant Gliomas
NCT01550523
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityPhase 1
TerminatedPanitumumab and Irinotecan for Malignant Gliomas
NCT01017653
Annick DesjardinsPhase 2
CompletedADV-TK Improves Outcome of Recurrent High-Grade Glioma
NCT00870181
Huazhong University of Science and TechnologyPhase 2